Silicom Ltd. , a leading provider of high-performance networking and data infrastructure solutions, today reported its financial results for the first quarter ended March 31, 2025.  Financial Results ...

"The excellent survival responses reported in patients with different tumor types in the Phase 2 study is very exciting, and ...

New immune data from the ongoing phase 2 trial with EVX-01 will be presented at a poster session tomorrow at the American Association for Cancer Research (AACR) Annual Meeting taking place in Chicago.